Massive new TB vaccine trial secures $550m in funding from two philanthropic organisations
A massive and much-anticipated Phase 3 trial of an experimental tuberculosis vaccine is set to proceed after funding was secured from two large philanthropies. If the trial’s findings are positive, the vaccine is likely to become the first new TB vaccine in more than 100 years to be widely used...
Source: dailymaverick.co.za